Literature DB >> 32697816

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.

Jeremy D Rubinstein1,2, Xiang Zhu3, Carolyn Lutzko1,3, Tom Leemhuis4, Jose A Cancelas1,3,4, Sonata Jodele1,2, Catherine M Bollard5,6, Patrick J Hanley5,6, Stella M Davies1,2, Michael S Grimley1,2, Adam S Nelson1,2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32697816      PMCID： PMC7391136          DOI： 10.1182/bloodadvances.2020002252

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

1.  Fatal adenovirus infection indistinguishable from thrombotic microangiopathy after allogeneic CD34+ peripheral progenitor cell transplantation.

Authors:  Hiromasa Yabe; Kinya Hattori; Hiroyasu Inoue; Masae Matsumoto; Satoshi Hamanoue; Aiko Hiroi; Takashi Koike; Shunichi Kato; Kazuo Shimamura; Miharu Yabe
Journal:  Tokai J Exp Clin Med       Date:  2005-04

2.  Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

Authors:  Anastasia Papadopoulou; Ulrike Gerdemann; Usha L Katari; Ifigenia Tzannou; Hao Liu; Caridad Martinez; Kathryn Leung; George Carrum; Adrian P Gee; Juan F Vera; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

3.  Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.

Authors:  Sonata Jodele; Christopher E Dandoy; Lara Danziger-Isakov; Kasiani C Myers; Javier El-Bietar; Adam Nelson; Gregory Wallace; Ashley Teusink-Cross; Stella M Davies
Journal:  Biol Blood Marrow Transplant       Date:  2016-04-07       Impact factor: 5.742

4.  Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Christoph Licht; Jens Goebel; Bradley P Dixon; Kejian Zhang; Theru A Sivakumaran; Stella M Davies; Fred G Pluthero; Lily Lu; Benjamin L Laskin
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

5.  Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Ifigeneia Tzannou; Anastasia Papadopoulou; Swati Naik; Kathryn Leung; Caridad A Martinez; Carlos A Ramos; George Carrum; Ghadir Sasa; Premal Lulla; Ayumi Watanabe; Manik Kuvalekar; Adrian P Gee; Meng-Fen Wu; Hao Liu; Bambi J Grilley; Robert A Krance; Stephen Gottschalk; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen; Bilal Omer
Journal:  J Clin Oncol       Date:  2017-08-07       Impact factor: 44.544

Review 6.  Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.

Authors:  Sabine Breuer; Margit Rauch; Susanne Matthes-Martin; Thomas Lion
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.476

Review 7.  Complement and human T cell metabolism: Location, location, location.

Authors:  Erin E West; Natalia Kunz; Claudia Kemper
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 10.983

8.  Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.

Authors:  Cristiana C Garcia; Wynne Weston-Davies; Remo C Russo; Luciana P Tavares; Milene A Rachid; José C Alves-Filho; Alexandre V Machado; Bernhard Ryffel; Miles A Nunn; Mauro M Teixeira
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Immunity to viruses.

Authors:  Thomas J Braciale; Young S Hahn
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

10.  Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

Authors:  Lisa E Gralinski; Timothy P Sheahan; Thomas E Morrison; Vineet D Menachery; Kara Jensen; Sarah R Leist; Alan Whitmore; Mark T Heise; Ralph S Baric
Journal:  mBio       Date:  2018-10-09       Impact factor: 7.867
View more
  2 in total

1.  Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?

Authors:  Sonata Jodele; Christopher E Dandoy; Anthony Sabulski; Jane Koo; Adam Lane; Kasiani C Myers; Gregory Wallace; Ranjit S Chima; Ashley Teusink-Cross; Russel Hirsch; Thomas D Ryan; Stefanie Benoit; Stella M Davies
Journal:  Transplant Cell Ther       Date:  2022-04-29

2.  Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure.

Authors:  Anthony Sabulski; Kasiani C Myers; Jack J Bleesing; Alexandra Duell; Adam Lane; Ashley Teusink-Cross; Stella M Davies; Sonata Jodele
Journal:  Blood Adv       Date:  2021-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.